The need for improved half-life extension technologies
DDNews DECEMBER 2015 | VOL. 11 | NO. 12
Pub type: Veltis
"Recent enabling half-life extension technologies are based on serum albumin, a natural, non-immunogenic plasma carrier protein. Albumin is an optimal material upon which to base half-life extension technologies due to its naturally long half-life of 19 days in humans, in comparison to protein therapeutics that are often cleared from the body in as little as hours."